The medication experience: a biopsychosocial approach in community pharmacy
DOI:
https://doi.org/10.60103/phc.v28.e945Keywords:
Pharmacotherapy Optimization, Medication Experience, Quality of Life, Needs Assessment, Health EducationAbstract
Introduction: This study evaluates the impact of Comprehensive Medication Management on a group of five patients attended at San Francisco Javier Pharmacy (Arrecife, Lanzarote).
Method: A mixed-methods, observational, and prospective study was conducted over a maximum period of six months. Data was collected through in-depth interviews, review of pharmaceutical records, and clinical assessments. Drug therapy problems were identified, and individualized interventions were designed for each patient. Quality of life was also assessed using EQ-5D-5L, EQ-VAS, and QALYs.
Results: Twenty-one drug therapy problems were identified in 5 patients, of which 20 (95.2%) were resolved through medication discontinuation, substitutions, dose adjustments, and health education. The most frequent were unmet needs for additional treatment (23.8%), unnecessary medication (19.0%), and adverse drug reactions (14.3%). Clinical evaluation showed nine resolved conditions, fourteen stable, six improved, three partially improved, and one worsened, including two new conditions identified during follow-up. The medication experience was predominantly positive, with good understanding of treatment and health-oriented motivations, although some concerns regarding dependency and drug efficacy were noted. Quality of life improved in all patients, with Patient 4 showing a 13.3 QALY gain and reduced anxiety/depression.
Conclusion: Comprehensive Medication Management proved effective in resolving drug therapy problems, improving clinical outcomes, and optimizing the medication experience. The results highlight its potential as both a clinical and humanistic tool, emphasizing the importance of interdisciplinary collaboration in patient-centered pharmaceutical care.
Downloads
References
Machuca M, Paciaroni J, Mastroianni P, Arriagada L, Silva Castro MM, et al. Guía para la implantación de servicios de Gestión Integral de la Farmacoterapia. OFIL; 2012.
SEDOF. Sociedad Española de Optimización de la Farmacoterapia. Guía de Acreditación de Unidades de Optimización de la Farmacoterapia (UOF) 2024-25. Madrid: SEDOF; 2025. Disponible en: https://www.sedof.org/images/documentos/Guia_Acreditacion_UOF_2024-25.pdf
Serrano Uribe A, Silva Castro MM, Olivella Cicero FA, Lanchero Cáceres PX, Durán Blanco TC. Integración del modelo biopsicosocial en la implantación de Comprehensive Medication Management para pacientes tratados en una institución oncológica en Colombia. Pharmaceutical Care España. 2023;25(5):20–39.
Orozco-Solano S, Silva-Castro MM, Machuca M. Experiencia con la medicación e intervenciones clínicas en pacientes valorados por farmacéuticos: revisión de alcance. Farm Hosp. 2023;47(5):230–242.
Pérez-Rodríguez RO, González-Valdivieso M, Silva-Castro MM. Entrevistas en profundidad: técnica complementaria a las entrevistas clínicas en las intervenciones basadas en necesidades del paciente. Pharmaceutical Care España. 2021;23(5):34–41.
Gómez-Barriga MD, Pacheco Del Cerro E, Fernández Del Palacio E, Vila-Costa I. Navigating innovation: Qualitative insights on using technology for health education in acute Coronary Syndrome patients. Clin Cardiol Cardiovasc Interv. 2024;7(7):01–06.
Vázquez-Vela V, Sánchez-Matamoros P, Bermúdez-Tamayo C, Gavira-Moreno R, López-Muñoz MJ, Silva-Castro MM. Gestión Integral de la Farmacoterapia a pacientes ambulatorios oncohematológicos en el contexto de la pandemia de COVID-19. Rev OFIL. 2024;34(2). Disponible en: https://www.ilaphar.org/gestion-integral-de-la-farmacoterapia-a-pacientes-ambulatorios-oncohematologicos-en-el-contexto-de-la-pandemia-de-covid-19-un-desafio-o-una-oportunidad/
McFarland MS, Buck ML, Crannage E, Armistead LT, Ourth H, Finks SW, et al. Assessing the impact of comprehensive medication management on achievement of the quadruple aim. Am J Med. 2021;134(4):456–461.
Kuo T, Chen S, Oh SM, Barragan NC, American Heart Association Western States Chronic Disease Prevention and Management Committee. Comprehensive medication management as a standard of practice for managing uncontrolled blood pressure. Front Med. 2021;8:693171.
Chung TH, Hernandez RJ, Libaud-Moal A, Nguyen LK, Lal LS, Swint JM, et al. The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment program. BMC Health Serv Res. 2020;20(1).
Sousa MCVB, Nascimento E, Mendonça SA, Chemello C. Professionals’ and patients’ perspectives on criteria for referring hypertensive patients to comprehensive medication management services in public primary health care. Int J Environ Res Public Health. 2023;20(7):5233.
Pestka DL, Paterson NL, Brummel AR, Norman JA, White KM. Barriers and facilitators to implementing pharmacist-provided comprehensive medication management in primary care transformation. Am J Health Syst Pharm. 2022;79(15):1255–1265.
Sancho-Vargas N, Zavaleta-Monestel E, Arguedas-Chacón S. Impact of a comprehensive medication management program on ambulatory care patients with noncommunicable diseases in a Latin American hospital: A retrospective study. J Am Coll Clin Pharm. 2023;6(3):276–283.
Rojas EI, Dupotey NM, De Loof H. Comprehensive Medication Management services with a holistic Point of View, a scoping review. Pharmacy (Basel). 2023;11(1):37.
Cachafeiro-Pin AI, Villaverde-Piñeiro L, Martín-Clavo S, Silva-Castro MM. Necesidades y experiencia farmacoterapéutica de los pacientes con leucemia mieloide crónica tratados con inhibidores de la tirosina cinasa: revisión sistemática. Farm Hosp. 2023;47(2):85–92.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The patient-centered approach to medication management services. 3rd ed. New York: McGraw-Hill; 2012.
Engels L, van den Akker M, Denig P, Stoffers H, Gerger H, Bohnen J, Jansen J. Medication management in patients with polypharmacy in primary care: a scoping review of clinical practice guidelines. J Evid Based Med.2025;18(1):e70015. doi:10.1111/jebm.70015.
Morales M, Rojas EI, Fuentes L, Villalona B, Dupotey NM. Implementación piloto de la gestión integral de la farmacoterapia a pacientes hospitalizados con enfermedades cardiovasculares [Comprehensive medication management for inpatients with cardiovascular diseases]. J Pharm Pharmacogn Res. 2024;12(4):673-682. doi:10.56499/jppres23.1786_12.4.673.
Umeh AU, Chima UE, Agbo CE, Chiekwe OS, Eze AE, Nwachuya CA, Mmuo SS, Nnedu CE, Isah A. Pharmacist-led medication therapy management: impact on healthcare utilization and costs. Am J Pharmacother Pharm Sci.2025;4(4):4. doi:10.25259/AJPPS_2025_004.
Baralić Knežević IR, Arsenović BM, Stefanović KD, Trifunović Balanović DM. Identification of drug-related problems during pharmaceutical care services: introduction to the geriatric department at the University Medical Center. Opšta Medicina. 2024;30(1-2). doi:10.5937/opmed0-48159.
Guo X, Wang Y, Wu J, Hu X. Medication multiple experiences of elderly patient with multiple chronic condition: a qualitative meta-synthesis. PLoS One. 2025;20(9):e0331753. doi:10.1371/journal.pone.0331753.
Thorakkattil SA, Parakkal SA, Mohammed Salim KT, Arain S, Krishnan G, Madathil H, et al. Improving patient safety and access to healthcare: the role of pharmacist-managed clinics in optimizing therapeutic outcomes. Explor Res Clin Soc Pharm. 2024;16:100527. doi:10.1016/j.rcsop.2024.100527.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rafael Omar Pérez-Rodríguez, María González-Valdivieso, María Amparo Blázquez-Ferrer
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
